期刊文献+

压力超负荷所致心肌肥厚中程序性坏死的初步研究 被引量:4

Preliminary Study of Necroptosis in Cardiac Hypertrophy Induced by Pressure Overload
原文传递
导出
摘要 本研究旨在观察压力超负荷所致心肌肥厚的病理生理过程中是否发生细胞程序性坏死及洛沙坦对这一病理生理过程的影响。实验采用腹主动脉缩窄术(TAC)建立压力超负荷导致的心肌肥厚大鼠模型,通过动脉血压、超声心动图、左心室质量指数、心肌肥厚分子标志物等观察左心室的结构功能变化。用real-time PCR和Western blot法分别检测程序性坏死标志物——受体相互作用蛋白激酶1和3(RIPK1和RIPK3)的基因和蛋白表达变化。结果表明,SD大鼠TAC术后4周可发生心肌肥厚。心肌组织中RIPK1/RIPK3的表达升高,HE染色发现坏死样心肌组织,电镜结果显示线粒体结构受损,提示心肌细胞可能发生程序性坏死。给予TAC大鼠血管紧张素Ⅱ受体拮抗剂洛沙坦治疗,大鼠心脏结构及功能明显改善,心肌肥厚程度减轻,而且对心肌肥厚过程中的程序性坏死有明显的抑制作用。 The aim of this study was to observe whether necroptosis is involved in the process of cardiac hypertrophy induced by pressure overload.SD rats underwent transverse abdominal aortic constriction(TAC)operation for establishing cardiac hypertrophy model.The structure and function of the left ventricle of rats were evaluated via echocardiography,left ventricular mass index,the expression of markers of cardiac hypertrophy and histological detection.Real-time PCR and Western blot were used to measure the gene and protein expression of receptor interacting protein kinase 1and 3(RIPK1and RIPK3,the necroptosis markers)respectively.Four weeks after TAC operation,rat model for cardiac hypertrophy was established.The experimental data showed that the gene and protein expressions of RIPK1 and RIPK3in the rat heart hypertrophic tissues after TAC for 4weeks were increased significantly compared with those in the sham group.HE staining showed cardiomyocytes injury and hypertrophy in the hearts of TAC rat models.By transmission electron microscope,we observed that mitochondria of cardiomyocytes were damaged seriously in the TAC models.Treatment with losartan used,the selective antagonist of angiotensin ⅡtypeⅠreceptor could improve the cardiac function of TAC rats.Moreover,losartan treatment decreased the expression of RIPK1 and RIPK3in heart tissues of TAC rats.The results suggest that necroptosis occurrs in the process of cardiac hypertrophy with pressure overload,and losartan could alleviate the cardiac hypertrophy and inhibit necroptosis.
出处 《生物医学工程学杂志》 CAS CSCD 北大核心 2015年第3期618-623,共6页 Journal of Biomedical Engineering
基金 国家自然科学基金资助项目(11072163,11372204) 高等学校博士学科点基金资助项目(20120181110012) 四川省科技厅资助项目(2010FZ0092)
关键词 程序性坏死 洛沙坦 压力超负荷 腹主动脉缩窄 necroptosis losartan pressure overload transverse abdominal aortic constriction
  • 相关文献

参考文献19

  • 1BERNARDO B C, WEEKS K L, PRETORIUS L A. Molec- ular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies [J].PharmacolTher, 2010, 128(1): 191-227.
  • 2LUEDDE M, LUTZ M, CARTER N, et al. RIP3, a kinase promoting necroptotic cell death, mediates adverse remodel- ling after myocardial infarction [J]. Cardiovasc Res, 2014, 103(2) : 206-216.
  • 3GUO F, SUN V B, SU L, et al. Losartan attenuates pa- raquat-indueed pulmonary fibrosis in rats [J]. Hum Exp Tox- icol, 2014 : doi: 10.1177/0960327114543840.
  • 4ZAKYNTHINOS E, PIERUTSAKOS Ch, KONSTANTINI- DIS K, et al. Losartan reduces left ventricular hypertrophy proportionally to blood pressure reduction in hypertensives, but does not affect diastolic cardiac function [J]. Angiology, 2004, 55(6): 669-678.
  • 5GARCIA-REDONDO A B, BRIONES A M, AVENDANO M S, et al. Losartan and tempol treatments normalize the in- creased response to Hydrogen peroxide in resistance arteries from hypertensive rats [J]. J Hypertens, 2009, 27(9): 1814- 1822.
  • 6PARK C S, CHA H, KWON E J, et al. The chemical chap- erone 4-phenylbutyric acid attenuates pressure-overload cardi-ac hypertrophy by alleviating endoplasmic reticulum stress [J]. Biochem Biophys Res Commun, 2012, 421(3): 578- 584.
  • 7DEALMEIDA A C, VAN OORT R J, WEHRENS X H. Transverse aortic constriction in mice [J]. J Vis Exp, 2010, (38) :doi: 10. 3791/1729.
  • 8CHA Jihei, LEE H R, KIM K C, et al. Changes of gene ex- pressions in spontaneously hypertensive rat model after losar- tan treatment[J]. Korean Circ J, 2012, 42(11) : 761-768.
  • 9HUAI Yong, WANG Haiyan, ZHAO Lei, et al. Lacidipine inhibits endoplasmic reticulum stress and myocardial remode- ling induced by pressure overload in rat heart[J].Eur J Phar- macol, 2013, 718(1-3): 441-447.
  • 10FRIMAN S, WALLIN M, GUSTAFSSON B I, et al. Sym- pathetic nerves do not affect experimental ischemia-reperfu- sion injury of rat liver [J]. Transplant Proc, 2009, 41 (2) : 743-745.

二级参考文献12

  • 1FERNANNDEZ-TWIINN D S, BLACKMORE H L, SIGGENS L, et al. The programming of cardiac hypertrophy in the offspring by maternal obesity is associated with hyperinsulinernia , AKT, ERK, and mTOR activation[J]. Endocrinology, 2012, 153(12), 5961-597l.
  • 2FUKUHARA A, MATSUDA M, NISHIZAWA M, et al. Visfatin , a protein secreted by visceral fat that mimics the effects of insulin[J]. Science, 2005, 307( 5708) ,426-430.
  • 3USLU S, KEBAPCl N, KARA M, et al. Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus[J]. Exp Ther Med, 2012,4(1),113-120.
  • 4CHANG L, YANG R, WANG M, et al. Angiotensin IT type-I receptor-J AK/ST AT pathway mediates the induction of visfatin in angiotensin IT -induced cardiomyocyte hypertrophy[n AmJ Medi Sci, 2012, 343(3), 220-226.
  • 5SCHULZE PC, BIOLO A, GOPAL D, et al. Dynamics in insulin resistance and plasma levels of adipokines in patients with acute decompensated and chronic stable heart failure[nJ Card Fail, 2011, 17(12) ,1004-101l.
  • 6MINAMI NO T, KOMURO I, KITAKAZE M. Endoplasmic reticulum stress as a therapeutic target in cardiovascular disease OJ. Circ Res, 2010, 107(9), 1071-1082.
  • 7JEONG K, KWON H, MIN C, et al. Modulation of the caveolin-3 localization to caveolae and ST A T3 to mitochondria by catecholamine-induced cardiac hypertrophy in H9c2 cardiomyoblasts OJ. Exp Mol Med, 2009, 41(4) ,226-235.
  • 8WATKINS SJ, BORTHWICK G M, ARTHUR H M. The H9c2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro[J]. In Vitro Cell Dev Bioi Anim , 2011, 47(2), 125-13l.
  • 9ROMACHO T, AZCUTIA V, VAZQUEZ-BELLA M, et al. Extracell ular PBEF / N AMPT / visfa tin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity[J]. Diabetologia , 2009, 52(11), 2455-2463.
  • 10BAE M K, SU-RYUN K, SOO-KYUNG B. Visfatin enhances ICAM-l and VCAM-l expression through ROS-dependent NF-kappa B activation in endothelial cells[J]. FebsJ, 2009, 276,187-188.

共引文献5

同被引文献22

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部